InfuSystem Holdings INFU Patient Services and Device Solutions — Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by InfuSystem Holdings in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: InfuSystem Holdings’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about InfuSystem Holdings's patient services and device solutions — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is InfuSystem Holdings's patient services and device solutions — revenue?
- InfuSystem Holdings (INFU) reported patient services and device solutions — revenue of $26.26M in Q1 2026.
- How has InfuSystem Holdings's patient services and device solutions — revenue changed year-over-year?
- InfuSystem Holdings's patient services and device solutions — revenue decreased by 2.5% year-over-year, from $26.93M to $26.26M.
- What is the long-term trend for InfuSystem Holdings's patient services and device solutions — revenue?
- Over 4 years (2021 to 2025), InfuSystem Holdings's patient services and device solutions — revenue has grown at a 8.8% compound annual growth rate (CAGR), from $80.7M to $113.08M.
- What does patient services and device solutions — revenue mean?
- This metric represents the total gross revenue generated by the specific business segment focused on patient services and medical device solutions. It reflects the company's ability to monetize its outpatient care facilitation and durable medical equipment services. Growth in this figure indicates successful expansion of the company's core service offerings and market penetration within the healthcare provider network.